BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 22093856)

  • 1. Dyslipidemia and pediatric obesity.
    Cook S; Kavey RE
    Pediatr Clin North Am; 2011 Dec; 58(6):1363-73, ix. PubMed ID: 22093856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dyslipidemia in the metabolic syndrome in children.
    Gidding SS
    J Cardiometab Syndr; 2006; 1(4):282-5. PubMed ID: 17679808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid Screening in Childhood and Adolescence for Detection of Multifactorial Dyslipidemia: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Lozano P; Henrikson NB; Morrison CC; Dunn J; Nguyen M; Blasi PR; Whitlock EP
    JAMA; 2016 Aug; 316(6):634-44. PubMed ID: 27532918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Childhood obesity: a simple equation with complex variables.
    Strock GA; Cottrell ER; Abang AE; Buschbacher RM; Hannon TS
    J Long Term Eff Med Implants; 2005; 15(1):15-32. PubMed ID: 15715513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing diabetic dyslipidemia: aggressive approach.
    Spratt KA
    J Am Osteopath Assoc; 2009 May; 109(5 Suppl):S2-7. PubMed ID: 19451254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of hypertension and dyslipidemia.
    Ferdinand KC; Kleinpeter MA
    Curr Hypertens Rep; 2006 Dec; 8(6):489-96. PubMed ID: 17087859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing cardiovascular risk in overweight children and adolescents.
    Dhuper S; Buddhe S; Patel S
    Paediatr Drugs; 2013 Jun; 15(3):181-90. PubMed ID: 23580344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity and dyslipidemia in South Asians.
    Misra A; Shrivastava U
    Nutrients; 2013 Jul; 5(7):2708-33. PubMed ID: 23863826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of genetic, biochemical and environmental factors on insulin resistance and obesity in Mexican young adults.
    Flores-Viveros KL; Aguilar-Galarza BA; Ordóñez-Sánchez ML; Anaya-Loyola MA; Moreno-Celis U; Vázquez-Cárdenas P; García-Gasca T
    Obes Res Clin Pract; 2019; 13(6):533-540. PubMed ID: 31796261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004.
    Nguyen NT; Magno CP; Lane KT; Hinojosa MW; Lane JS
    J Am Coll Surg; 2008 Dec; 207(6):928-34. PubMed ID: 19183541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of dyslipidemia in the metabolic syndrome.
    Tan KC
    Cardiovasc Hematol Disord Drug Targets; 2007 Jun; 7(2):99-108. PubMed ID: 17584044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Childhood obesity and dyslipidemia].
    Gómez-Díaz RA; Wacher-Rodarte NH
    Rev Med Inst Mex Seguro Soc; 2014; 52 Suppl 1():S102-8. PubMed ID: 24866316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of diabetes and associated cardiometabolic risk factors on members: strategies for optimizing outcomes.
    Hoerger TJ; Ahmann AJ
    J Manag Care Pharm; 2008 Feb; 14(1 Suppl C):S2-14; quiz 15-6. PubMed ID: 18240890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing mixed dyslipidemia in special populations.
    Miller M
    Prev Cardiol; 2010; 13(2):78-83. PubMed ID: 20377810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe dyslipidemia and concomitant risk factors in the middle-aged Lithuanian adults: a cross-sectional cohort study.
    Kutkienė S; Petrulionienė Ž; Laucevičius A; Petrylaitė M; Maskeliūnaitė D; Puronaitė R; Kovaitė M; Kalibaitaitė I; Rinkūnienė E; Dženkevičiūtė V; Kasiulevičius V
    Lipids Health Dis; 2018 Apr; 17(1):88. PubMed ID: 29673349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis.
    Jellinger PS; Smith DA; Mehta AE; Ganda O; Handelsman Y; Rodbard HW; Shepherd MD; Seibel JA;
    Endocr Pract; 2012; 18 Suppl 1():1-78. PubMed ID: 22522068
    [No Abstract]   [Full Text] [Related]  

  • 17. 2018 Guidelines for the management of dyslipidemia.
    Rhee EJ; Kim HC; Kim JH; Lee EY; Kim BJ; Kim EM; Song Y; Lim JH; Kim HJ; Choi S; Moon MK; Na JO; Park KY; Oh MS; Han SY; Noh J; Yi KH; Lee SH; Hong SC; Jeong IK
    Korean J Intern Med; 2019 Jul; 34(4):723-771. PubMed ID: 31272142
    [No Abstract]   [Full Text] [Related]  

  • 18. American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis: executive summary.
    Jellinger PS; Smith DA; Mehta AE; Ganda O; Handelsman Y; Rodbard HW; Shepherd MD; Seibel JA;
    Endocr Pract; 2012; 18(2):269-93. PubMed ID: 22507559
    [No Abstract]   [Full Text] [Related]  

  • 19. Dyslipidemia and glucose dysregulation in overweight and obese patients.
    LeRoith D
    Clin Cornerstone; 2007; 8(3):38-52. PubMed ID: 18452841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parameters of Metabolic Syndrome in Obese Children and Adolescents.
    Kostovski M; Gucev Z; Tasic V; Polenakovic M
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2018 Jul; 39(1):105-114. PubMed ID: 30110260
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.